"Malnutrition-inflammation complex syndrome" in chronic hemodialysis;"Sindrome complejo de malnutricion e inflamacion" en la hemodialisis cronica

Medicina

Volumn 71, Issue 1, 2011, Pages 66-72

  Young, Pablo ^a   Lombi, Fernando ^a   Finn, Barbara C ^a   Forrester, Mariano ^a   Campolo Girard, Vicente ^a   Pomeranz, Vanesa ^a   Iriarte, Romina ^a   Bruetman, Julio E ^a   Trimarchi, Hernaan ^a  

^a HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

Author keywords

Cardiovascular disease; Dialysis; Inflammation; Protein energy malnutrition; Reverse epidemiology

Indexed keywords

ERYTHROPOIETIN; UREMIC TOXIN;

APPETITE DISORDER; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CATABOLISM; COMORBIDITY; HEMODIALYSIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERMETABOLISM; HYPERPHOSPHATEMIA; INFLAMMATION; LONG TERM CARE; MALNUTRITION; MALNUTRITION INFLAMMATION COMPLEX SYNDROME; OXIDATIVE STRESS; PROTEIN CALORIE MALNUTRITION; QUALITY OF LIFE; RISK FACTOR;

HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; PROTEIN-ENERGY MALNUTRITION; RENAL DIALYSIS; RISK FACTORS; SYNDROME;

EID: 79959228481     PISSN: 00257680     EISSN: 16699106     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Stenvinkel P, Heimbürger O, Lindholm B, Kaysen GA, Bergström J. Are there two types of malnutrition in chronic renal failure? Evidence of relationships between malnutrition, inflammation and atherosclerosis. Nephrol Dial Transplant 2000; 15: 953-60.
2. O'keefe A, Daigle NW. A new approach to classifying malnutrition in the hemodialysis patient. J Renal Nut 2002; 12: 248-55.
3. Rambod M, Kovesdy CP, Kalantar-Zadeh K. Malnutrition-inflammation score for risk stratification of patients with CKD: is it the promised gold standard? Nat Clin Pract Nephrol 2008; 4: 354-5.
4. Landray MJ, Wheeler DC, Lip GY, et al. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. Am J Kidney Dis 2004; 43: 244-53.
5. Kalantar-Zadeh K, Ikizler A, Block G, Avram MM, Kopple JD. Malnutrition-Inflammation Complex Syndrome in dialysis patients: Causes and consequences (Review). Am J Kidney Dis 2003; 42: 864-81.
6. Ikizler TA. Nutrition, inflammation and chronic kidney disease (Review). Curr Opin Nephrol Hypertens 2008; 17: 162-7.
7. Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008; 73: 391-8.
8. Meyer TW, Hostetter TH. Uremia. N Engl J Med 2007; 357: 1316-25.
9. Abboud H, Henrich WL. Stage IV Chronic Kidney Disease. N Engl J Med 2010; 362: 56-65.
10. Ikizler TA, Wingard RL, Harvell J, Shyr Y, Hakim RM. Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study. Kidney Int 1999; 55: 1945-51.
11. Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentrations as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993; 329: 1001-6.
12. Kimmel PL, Phillips TM, Simmens SJ, et al. Immunologic function and survival in hemodialysis patients. Kidney Int 1998; 54: 236-44.
13. Snaedal S, Heimbürger O, Qureshi AR, et al. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival. Am J Kidney Dis 2009; 53: 1024-33.
14. Stenvinkel P, Heimbürger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899-1911.
15. Qureshi AR, Alvestrand A, Danielsson A, et al. Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int 1998; 53: 773-82.
16. Bergström J, Lindholm B, Lacson E Jr, et al. What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients? Semin Dial 2000; 13: 163-75.
17. Bistrian BR. Role of the systemic inflammatory response syndrome in the development of protein-calorie malnutrition in ESRD. Am J Kidney Dis 1998; 32: S113-S117.
18. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 2001; 38: 1251-63.
19. Yamada K, Furuya R, Takita T, et al. Simplified nutritional screening tools for patients on maintenance hemodialysis. Am J Clin Nutr 2008; 87: 106-13.
20. Dessì M, Noce A, Agnoli A, et al. The usefulness of the prognostic inflammatory and nutritional index (PINI) in a haemodialysis population. Nutr Metab Cardiovasc Dis 2009; 19: 811-5.
21. Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimbürger O, Massy Z. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: How do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 2008; 3: 505-21.
22. Cheung AK, Sarnak MJ, Yan G, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000; 58: 353-62.
23. Muntner P, Hamm LL, Kusek JW, Chen J, Whelton PK, He J. The prevalence of non-traditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 2004; 140: 9-17.
24. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant of uremia: oxidative stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002; 62: 1524-38.
25. Lee CJ, Ramirez C, Thomson LE. A stone heart: fatal cardiac microcalcification. Eur Heart J 2007; 28: 2312.
26. Menon V, Lijun L, Wang X, et al. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 2006; 17: 2599-2606.
27. Kalantar-Zadeh K, Kovesdy CP, Derose SF, Horwich TB, Fonarow GC. Racial and survival paradoxes in chronic kidney disease. Nat Clin Pract Nephrol 2007; 3: 493-506.
28. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003; 63: 793-808.
29. Ades PA, Savage PD. The obesity paradox: Perception vs knowledge. Mayo Clin Proc 2010; 85: 112-5.
30. Lowrie E, Lew N. Death risk in hemodialysis patients: The predictive value of commonly measures variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15: 458-82.
31. Eustace JA, Astor B, Muntner PM, Ikizler TA, Coresh J. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int 2004; 65: 1031-40.
32. Ramos LF, Shintani A, Ikizler TA, Himmelfarb J. Contribution of adiposity to increased oxidative stress and inflammation in patients with moderate to severe chronic kidney disease. J Am Soc Nephrol 2008; 19: 593-9.
33. Jamieson JC, Kaplan HA, Woloski BM, Hellman M, Ham K. Glycoprotein biosynthesis during the acute-phase response to inflammation. Can J Biochem cell Biol 1983; 61: 1041-8.
34. Friedman AN, Fadem SZ. Reassessment of albumin as a nutritional marker in kidney disease. J Am Soc Nephrol 2010; 21: 223-30.
35. Moshage HJ, Janssen JA, Franssen JH, Hafkenscheid JC, Yap SH. Study of the molecular mechanims of decreased liver synthesis of albumin in inflammation. J Clin Invest 1987; 79: 1635-41.
36. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648-58.
37. Suffredini AF, Fantuzzi G, Badolato R, Oppenheim JJ, O'Grady NP. New insights into the biology of the acute phase response. J Clin Immunol 1999; 19: 203-14.
38. Trimarchi H, Mongitore MR, Baglioni P, et al. N-acetylcysteine reduces malondialdehyde levels in chronic hemodialysis patients-a pilot study. Clin Nephrol 2003; 59: 441-6.
39. Pecoits-Filho R, Lindholm B, Stenvinkel P. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome-the heart of the matter (Review). Nephrol Dial Transplant 2002: 17: 28-31.
40. Bergström J, Lindholm B, Lacson E Jr, et al. What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients? Semin Dial 2000; 13: 163-75.
41. Caglar K, Peng Y, Pupim LB, et al. Inflammatory signals associated with hemodialysis. Kidney Int 2002; 62: 1408-16.
42. Daugirdas JT, Tattersall J. Effect of treatment spacing and frequency on three measures of equivalent clearance, including standard Kt/V. Nephrol Dial Transplant 2010; 25: 558-61.
43. Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 2004: 80: 299-307.
44. Lopes AA, Bragg-Gresham JL, Elder SJ, et al. Independent and joint associations of nutritional status indicators with mortality risk among chronic hemodialysis patients in the dialysis outcomes and practice patterns study (DOPPS). J Ren Nutr 2010; 20: 224-34.
45. Dinarello CA, Roubenoff RA. Mechanisms of loss of lean body mass in patients on chronic dialysis (Review). Blood Purif 1996; 14: 388-94.
46. Scholze A, Rattensperger D, Zidek W, Tepel M. Low serum leptin predicts mortality in patients with chronic kidney disease stage 5. Obesity 2007; 15: 1617-22.
47. Bistrian BR. Role of the systemic inflammatory response syndrome in the development of protein-calorie malnutrition in ESRD. Am J Kidney Dis 1998; 32: S113-S117.
48. Kaysen GA. The microinflammatory state in uremia: causes and potential consequences (Review). J Am Soc Nephrol 2001; 12: 1549-57.
49. Tsujinaka T, Fujita J, Ebisui C, et al. Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J Clin Invest 1996; 97: 244-9.
50. Vlassara H, Cai W, Crandall J, et al. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetics angiopathy. Proc Natl Acad Sci USA 2002; 99: 15596-601.
51. Uribarri J, Peppa M, Cai W, et al. Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients. J Am Soc Nephrol 2003; 14: 728-31.
52. Uribarri J, Stirban A, Sander D, et al. Single oral challenge by advanced glycation end products acutely impairs endotelial function in diabetic and non diabetic subjets. Diabetes Care 2007; 30: 2579-82.
53. Trimarchi H, Duboscq C, Genoud V, et al. Plasminogen activator inhibitor-1 activity and 4G/5G polymorphism in hemodialysis. J Vasc Access 2008; 9: 142-7.
54. Spittle MA, Hoenich NA, Handelman GJ, Adhikarla R, Homel P, Levin NW. Oxidative stress and inflammation in hemodialysis patients. Am J Kidney Dis 2001; 38: 1408-13.
55. Richter A, Kuhlmann MK, Seibert E, Kotanko P, Levin NW, Handelman GJ. Vitamin C deficiency and secondary hyperparathyroidism in chronic haemodialysis patients. Nephrol Dial Transplant 2008; 23: 2058-63.
56. Trimarchi H, Young P, Díaz ML, Schropp J, Forrester M, Freixas E. La hiperhomocisteinemia como factor de riesgo vascular en hemodializados crónicos. Medicina (Buenos Aires) 2005; 65: 513-7.
57. Trimarchi H, Genoud V, Schiel A, et al. The C677T thermolabile variant of methylene tetrahydrofolate reductase on homocysteine, folate and vitamin B12 in a hemodialysis center. Medicina (Buenos Aires) 2002; 62: 149-53.
58. Trimarchi H, Schiel A, Freixas E, Díaz M. Randomized trial of methylcobalamin and folate effects on homocysteine in hemodialysis patients. Nephron 2002; 91: 58-63.
59. Lopez-Garcia E, van Dam RM, Qi L, Hu FB. Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr 2006; 84: 888-93.
60. Chrysohoou C, Panagiotakos DB, Pitsavos C, Das UN, Stefanadis C. Adherence to the mediterranean diet attenuates inflammation and coagulation process in healthy adults: the ATTICA study. J Am Coll Cardiol 2004; 44: 152-8.
61. Esposito K, Marfella R, Ciotola M, et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004; 292: 1440-6.
62. Fouque D, Vennegoor M, ter Wee P, et al. EBPG Guideline on Nutrition. Nephrol Dial Transplant 2007; 22 (suppl 2): ii45-ii87.
63. Pupim LB, Flakoll PJ, Brouillette JR, Levenhagen DK, Hakim RM, Ikizler TA. Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients. J Clin Invest 2002; 110: 483-92.
64. Pupim LB, Flakoll PJ, Ikizler TA. Nutritional supplementation acutely increases albumin fractional synthetic rate in chronic hemodialysis patients. J Am Soc Nephrol 2004; 15: 1920-6.
65. Biolo G, Ciocchi B, Bosutti A, Situlin R, Toigo G, Guarnieri G. Pentoxifylline acutely reduces protein catabolism in chronically uremic patients. Am J Kidney Dis 2002; 40: 1162-72.
66. Castaneda C, Gordon PL, Parker RC, Uhlin KL, Roubenoff R, Levey AS. Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease. Am J Kidney Dis 2004; 43: 607-16.
67. Chang JW, Yang WS, Min WK, Lee SK, Park JS, Kim SB. Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients. Am J Kidney Dis 2002; 39: 1213-7.
68. Seliger SL, Weiss NS, Gillen DL, et al. HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients. Kidney Int 2002; 61: 297-304.
69. Stenvinkel P, Andersson P, Wang T, et al. Do ACE-inhibitors suppress tumour necrosis factor-alpha production in advanced chronic renal failure? J Intern Med 1999; 246: 503-7.
70. Schulman G, Wingard RL, Hutchison RL, Lawrence P, Hakim RM. The effects of recombinant human growth hormone and intradialytic parenteral nutrition in malnourished hemodialysis patients. Am J Kidney Dis 1993; 21: 527-34.
71. Trimarchi H, Muryan A, Campolo-Girard V, et al. Increased levels of Pro-BNP, Troponin T and Malnutrition Inflammatory Score levels in chronic hemodialysis patients with overt cardiovascular disease. Nephron Clinical Practice 2010; 117: c198-c205.